Correlation Between Diamond Fields and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Diamond Fields and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamond Fields and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamond Fields Resources and Big Pharma Split, you can compare the effects of market volatilities on Diamond Fields and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamond Fields with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamond Fields and Big Pharma.
Diversification Opportunities for Diamond Fields and Big Pharma
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Diamond and Big is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Diamond Fields Resources and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Diamond Fields is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamond Fields Resources are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Diamond Fields i.e., Diamond Fields and Big Pharma go up and down completely randomly.
Pair Corralation between Diamond Fields and Big Pharma
Assuming the 90 days horizon Diamond Fields Resources is expected to generate 5.16 times more return on investment than Big Pharma. However, Diamond Fields is 5.16 times more volatile than Big Pharma Split. It trades about 0.03 of its potential returns per unit of risk. Big Pharma Split is currently generating about -0.02 per unit of risk. If you would invest 3.50 in Diamond Fields Resources on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Diamond Fields Resources or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Diamond Fields Resources vs. Big Pharma Split
Performance |
| Timeline |
| Diamond Fields Resources |
| Big Pharma Split |
Diamond Fields and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diamond Fields and Big Pharma
The main advantage of trading using opposite Diamond Fields and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamond Fields position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Diamond Fields vs. Canaf Investments | Diamond Fields vs. Atrium Mortgage Investment | Diamond Fields vs. Westshore Terminals Investment | Diamond Fields vs. Data Communications Management |
| Big Pharma vs. NovaGold Resources | Big Pharma vs. HPQ Silicon Resources | Big Pharma vs. Eastwood Bio Medical Canada | Big Pharma vs. Diamond Fields Resources |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |